// App-Quantinova.ai

TCT-468 : Safety and Efficacy Outcome After Implantation of a Novel Sirolimus-Eluting Stent in Real-World Patient Population: 3-Year Results From the en-Abl-e Registry

Researchers

Presenter

  • Sameer Dani

Principal Investigators

  • Luca Testa

Medical Centers

  • IRCCS Policlinico S. Donato, Milan, Italy

  • Apollo Hospital International, Ahmedabad, India

Locations

  • Italy

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved